New career strategy aims to address talent acquisition and retention requirements for capacity expansion
21 May 2014 – Sciformix Corporation, a leading Scientific Process Organization (SPO), will unveil a new strategic model for talent acquisition and retention at the DIA 50th Annual Meeting, San Diego, California, which will take place 15th to 19th June. The new model will demonstrate the ability to cater for the increasing demand for talent in the CRO industry, enabling capacity expansion without compromising productivity and the quality of deliverables.
The talent pool for the CRO industry is currently at a critical level, with an ever increasing demand for trained candidates, especially in highly skilled roles. The demand-supply skew has stretched the limit of current hiring practices aimed at external sourcing of experienced talent. The problem is more acute for companies such as Sciformix, that work in areas of high science and high domain where lateral hiring isn’t the solution.
Sciformix has implemented a novel model of systematized training by developing a structured curriculum both for entry level and experienced candidates. By focusing on in-house professional development, the program will provide not only a stream of trained resources, but also make experienced resources productive on complex assignments they don’t have prior experience on.
In a presentation, to take place at DIA 50th Annual Meeting on 19th June, Dr. Samyuktha Ajay, Practice Head for Clinical Research and Post-Approval Support Services at Sciformix, will outline this new strategic initiative and share the experience and benefits of the program.
Dr. Ajay said: “According to various market research reports, the CRO industry is expected to grow to $32.7 billion by next year, to over $65.0 billion by 2021, and has created an increased demand for a rich talent pool of medical, paramedical and science graduates to supply capacity expansion. CROs and their service providers are creating new positions and promoting internal employees which is driving significant movement amongst companies and, thus, creating further resource crunch. Despite candidates being readily available, finding the right match requires the adoption of a multi-dimensional strategy. Through sharing our extensive experience of in-house training at all levels, we aim to project a program which offers a structured career path and excellent retention strategy.”
The DIA 2014 50th annual meeting is the largest multidisciplinary event that brings together the community of life sciences professionals at all levels and across all disciplines involved in the discovery, development and life cycle management of medical products and therapies to patients. DIA will provide a platform to raise the level of discussion to facilitate innovation that will change the future of health care and it will provide coverage of the full development and life cycle management of process for health care products.
To meet with Sciformix at DIA and/or receive a copy of the presentation, contact us at Bizteam@sciformix.com .
To learn more about Sciformix visit www.sciformix.com , email us at email@example.com, or call us at +1.877.576.5005.
For further press information please contact: David Bertram, The Scott Partnership:
Sciformix Corporation is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies - in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs. Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, India and the Philippines.
We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.
Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.
The Scott Partnership
The Scott Partnership